Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor.
about
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.Identification of a potential pharmacological sanctuary for HIV type 1 in a fraction of CD4(+) primary cells.Genotypic testing for human immunodeficiency virus type 1 drug resistance.Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor.Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based populationThe Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
P2860
Q33593237-26944BDD-0C86-4C18-8395-5ED3861B6021Q33807628-F7FE54ED-6681-4140-8505-8B46B61D021FQ33906239-437B0B19-FE64-4A1D-8556-1F818B9295F3Q33981706-50DC55B6-3243-40CE-9ECB-35743E41BB04Q34073276-8EE305C5-AF8C-493D-AC54-A1AB9A39FB3CQ34454630-87768145-A71D-4C8A-91AE-B39CD971B759Q36239954-23207F54-EFD1-4355-B7D9-356F17EEEF7CQ36880577-7B163EC3-9599-4F3E-AEC9-9D3D02FEAB36Q36973809-E6E5FB5C-3076-4B16-8F15-692075452905Q37002721-7FD0806E-05C5-4B47-A1BD-FF24A9C1E9A2Q37018369-5DB80375-2A51-4C32-9685-017A13282A54Q39461924-3C479A67-7D6D-439D-9805-138343258E52
P2860
Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Polymorphism of the human immu ...... ients to a protease inhibitor.
@en
Polymorphism of the human immunodeficiency virus type 1
@nl
type
label
Polymorphism of the human immu ...... ients to a protease inhibitor.
@en
Polymorphism of the human immunodeficiency virus type 1
@nl
prefLabel
Polymorphism of the human immu ...... ients to a protease inhibitor.
@en
Polymorphism of the human immunodeficiency virus type 1
@nl
P2093
P2860
P1476
Polymorphism of the human immu ...... ients to a protease inhibitor.
@en
P2093
P2860
P304
P407
P577
1999-09-01T00:00:00Z